Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease.
In recent years, small protein oligomers have been implicated in the aetiology of a number of important amyloid diseases, such as type 2 diabetes, Parkinson's disease and Alzheimer's disease. As a consequence, research efforts are being directed away from traditional targets, such as amylo...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2009
|
_version_ | 1797050293398011904 |
---|---|
author | Bernstein, S Dupuis, N Lazo, N Wyttenbach, T Condron, M Bitan, G Teplow, D Shea, J Ruotolo, B Robinson, C Bowers, M |
author_facet | Bernstein, S Dupuis, N Lazo, N Wyttenbach, T Condron, M Bitan, G Teplow, D Shea, J Ruotolo, B Robinson, C Bowers, M |
author_sort | Bernstein, S |
collection | OXFORD |
description | In recent years, small protein oligomers have been implicated in the aetiology of a number of important amyloid diseases, such as type 2 diabetes, Parkinson's disease and Alzheimer's disease. As a consequence, research efforts are being directed away from traditional targets, such as amyloid plaques, and towards characterization of early oligomer states. Here we present a new analysis method, ion mobility coupled with mass spectrometry, for this challenging problem, which allows determination of in vitro oligomer distributions and the qualitative structure of each of the aggregates. We applied these methods to a number of the amyloid-β protein isoforms of Aβ40 and Aβ42 and showed that their oligomer-size distributions are very different. Our results are consistent with previous observations that Aβ40 and Aβ42 self-assemble via different pathways and provide a candidate in the Aβ42 dodecamer for the primary toxic species in Alzheimer's disease. |
first_indexed | 2024-03-06T18:03:02Z |
format | Journal article |
id | oxford-uuid:00783661-3665-4c26-92b8-783542c2a8f3 |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-06T18:03:02Z |
publishDate | 2009 |
record_format | dspace |
spelling | oxford-uuid:00783661-3665-4c26-92b8-783542c2a8f32022-03-26T08:29:40ZAmyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:00783661-3665-4c26-92b8-783542c2a8f3EnglishSymplectic Elements at Oxford2009Bernstein, SDupuis, NLazo, NWyttenbach, TCondron, MBitan, GTeplow, DShea, JRuotolo, BRobinson, CBowers, MIn recent years, small protein oligomers have been implicated in the aetiology of a number of important amyloid diseases, such as type 2 diabetes, Parkinson's disease and Alzheimer's disease. As a consequence, research efforts are being directed away from traditional targets, such as amyloid plaques, and towards characterization of early oligomer states. Here we present a new analysis method, ion mobility coupled with mass spectrometry, for this challenging problem, which allows determination of in vitro oligomer distributions and the qualitative structure of each of the aggregates. We applied these methods to a number of the amyloid-β protein isoforms of Aβ40 and Aβ42 and showed that their oligomer-size distributions are very different. Our results are consistent with previous observations that Aβ40 and Aβ42 self-assemble via different pathways and provide a candidate in the Aβ42 dodecamer for the primary toxic species in Alzheimer's disease. |
spellingShingle | Bernstein, S Dupuis, N Lazo, N Wyttenbach, T Condron, M Bitan, G Teplow, D Shea, J Ruotolo, B Robinson, C Bowers, M Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease. |
title | Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease. |
title_full | Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease. |
title_fullStr | Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease. |
title_full_unstemmed | Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease. |
title_short | Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease. |
title_sort | amyloid β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of alzheimer s disease |
work_keys_str_mv | AT bernsteins amyloidbproteinoligomerizationandtheimportanceoftetramersanddodecamersintheaetiologyofalzheimersdisease AT dupuisn amyloidbproteinoligomerizationandtheimportanceoftetramersanddodecamersintheaetiologyofalzheimersdisease AT lazon amyloidbproteinoligomerizationandtheimportanceoftetramersanddodecamersintheaetiologyofalzheimersdisease AT wyttenbacht amyloidbproteinoligomerizationandtheimportanceoftetramersanddodecamersintheaetiologyofalzheimersdisease AT condronm amyloidbproteinoligomerizationandtheimportanceoftetramersanddodecamersintheaetiologyofalzheimersdisease AT bitang amyloidbproteinoligomerizationandtheimportanceoftetramersanddodecamersintheaetiologyofalzheimersdisease AT teplowd amyloidbproteinoligomerizationandtheimportanceoftetramersanddodecamersintheaetiologyofalzheimersdisease AT sheaj amyloidbproteinoligomerizationandtheimportanceoftetramersanddodecamersintheaetiologyofalzheimersdisease AT ruotolob amyloidbproteinoligomerizationandtheimportanceoftetramersanddodecamersintheaetiologyofalzheimersdisease AT robinsonc amyloidbproteinoligomerizationandtheimportanceoftetramersanddodecamersintheaetiologyofalzheimersdisease AT bowersm amyloidbproteinoligomerizationandtheimportanceoftetramersanddodecamersintheaetiologyofalzheimersdisease |